Healthcare providers may implement the following recommendations from CDC effective immediately.

Pfizer COVID-19 Vaccine Booster Dose Recommendations

CDC updated recommendations for when people who receive the Pfizer-BioNTech COVID-19 vaccine may receive a COVID-19 booster shot. The interval for the booster shot was shortened from 6 months to 5 months only for people who received the Pfizer-BioNTech COVID-19 Vaccine. The booster interval recommendation for people who received the J&J vaccine (2 months) or the Moderna vaccine (6 months), has not changed. 

Additionally, consistent with prior recommendations for adults, CDC is recommending moderately or severely immunocompromised 5–11-year-olds receive an additional primary dose of vaccine 28 days after the second shot. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for children aged 5-11.

ACIP meets Wednesday, January 5, 2022 from 12:00 pm until 4:00 pm CST to discuss booster dose recommendations for 12-15 year old patients. The agenda, slides and link to the webcast can be found here. This meeting is virtual. No registration is required to watch the webcast. 

Healthcare provider questions regarding COVID-19 vaccine can be directed to the COVID-19 Vaccine Call Center at 1-800-831-6293 ext. 1 or emailed to